Frenkel-Morgenstern's team the only Israeli group to take part in groundbreaking study generating most comprehensive map of cancer genomes charted to date

Dr. Milana Frenkel-Morgenstern's team was the only Israeli group to take part in the genomics and transcriptomics studies of the Pan-Cancer Analysis of Whole Genomes Project (PCAWG), also known as the Pan-Cancer Project. A collaboration of over 1,300 scientists and clinicians from 37 countries, more than 2,600 genomes of 38 different tumor types, were analyzed, creating a huge resource of primary cancer genomes. Sixteen working groups studying many aspects of cancer’s development, causation, progression and classification ensued.

Two of the PanCancer papers resulting from this collaboration have just been published back-to-back in Nature, among five papers published in Nature from the PanCancer consortium: 

https://www.nature.com/articles/s41586-020-1970-0

https://www.nature.com/articles/s41586-020-1969-6

These projects were carried out over the past seven years and are the most comprehensive study of whole cancer genomes to date, significantly improving our understanding of cancer and offering new directions for diagnosis and treatment.